- Home
- SLGL
as of 03-09-2026 2:02pm EST
Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline includes SGT-610 (Patidegib Gel 2%), a new chemical entity hedgehog signaling pathway blocker, for the chronic use and prevention of new BCC in Gorlin syndrome patients, and the topical drug candidate SGT-210 for the treatment of Darier Disease and other rare keratosis-related indications such as PC, PPK and Olmsted.
| Founded: | 1997 | Country: | Israel |
| Employees: | N/A | City: | N/A |
| Market Cap: | 159.7M | IPO Year: | 2016 |
| Target Price: | $110.00 | AVG Volume (30 days): | 11.7K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | N/A | EPS Growth: | N/A |
| 52 Week Low/High: | $0.40 - $97.97 | Next Earning Date: | N/A |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | 122.71% | Revenue Growth (next year): | -79.04% |
| P/E Ratio: | N/A | Index: | N/A |
| Free Cash Flow: | N/A | FCF Growth: | N/A |
Stock Insider Trading Activity of Sol-Gel Technologies Ltd. (SLGL)
10% Owner
Avg Cost/Share
$63.00
Shares
291
Total Value
$18,333.00
Owned After
450,335
SEC Form 4
10% Owner
Avg Cost/Share
$58.00
Shares
100
Total Value
$5,800.00
Owned After
450,335
SEC Form 4
10% Owner
Avg Cost/Share
$57.05
Shares
100
Total Value
$5,705.00
Owned After
450,335
SEC Form 4
10% Owner
Avg Cost/Share
$42.98
Shares
198
Total Value
$8,510.04
Owned After
450,335
SEC Form 4
10% Owner
Avg Cost/Share
$41.92
Shares
2,394
Total Value
$100,347.86
Owned After
450,335
SEC Form 4
10% Owner
Avg Cost/Share
$41.99
Shares
22,497
Total Value
$944,743.52
Owned After
450,335
SEC Form 4
10% Owner
Avg Cost/Share
$41.99
Shares
35,169
Total Value
$1,476,626.74
Owned After
450,335
SEC Form 4
10% Owner
Avg Cost/Share
$41.85
Shares
8,638
Total Value
$361,533.99
Owned After
450,335
SEC Form 4
10% Owner
Avg Cost/Share
$41.68
Shares
1,626
Total Value
$67,764.53
Owned After
450,335
SEC Form 4
10% Owner
Avg Cost/Share
$41.66
Shares
260
Total Value
$10,832.46
Owned After
450,335
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| Opaleye Management Inc. | SLGL | 10% Owner | Feb 13, 2026 | Buy | $63.00 | 291 | $18,333.00 | 450,335 | |
| Opaleye Management Inc. | SLGL | 10% Owner | Feb 2, 2026 | Buy | $58.00 | 100 | $5,800.00 | 450,335 | |
| Opaleye Management Inc. | SLGL | 10% Owner | Jan 27, 2026 | Buy | $57.05 | 100 | $5,705.00 | 450,335 | |
| Opaleye Management Inc. | SLGL | 10% Owner | Jan 5, 2026 | Buy | $42.98 | 198 | $8,510.04 | 450,335 | |
| Opaleye Management Inc. | SLGL | 10% Owner | Jan 2, 2026 | Buy | $41.92 | 2,394 | $100,347.86 | 450,335 | |
| Opaleye Management Inc. | SLGL | 10% Owner | Dec 31, 2025 | Buy | $41.99 | 22,497 | $944,743.52 | 450,335 | |
| Opaleye Management Inc. | SLGL | 10% Owner | Dec 30, 2025 | Buy | $41.99 | 35,169 | $1,476,626.74 | 450,335 | |
| Opaleye Management Inc. | SLGL | 10% Owner | Dec 29, 2025 | Buy | $41.85 | 8,638 | $361,533.99 | 450,335 | |
| Opaleye Management Inc. | SLGL | 10% Owner | Dec 26, 2025 | Buy | $41.68 | 1,626 | $67,764.53 | 450,335 | |
| Opaleye Management Inc. | SLGL | 10% Owner | Dec 23, 2025 | Buy | $41.66 | 260 | $10,832.46 | 450,335 |
Compare SLGL vs Leading Stocks
See how SLGL stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "SLGL Sol-Gel Technologies Ltd. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.